- Home
- PEN vs EVR Comparison
PEN vs EVR Comparison
Compare PEN & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEN
- EVR
- Stock Information
- Founded
- PEN 2004
- EVR 1995
- Country
- PEN United States
- EVR United States
- Employees
- PEN N/A
- EVR N/A
- Industry
- PEN Medical/Dental Instruments
- EVR Investment Managers
- Sector
- PEN Health Care
- EVR Finance
- Exchange
- PEN Nasdaq
- EVR Nasdaq
- Market Cap
- PEN 10.6B
- EVR 8.7B
- IPO Year
- PEN 2015
- EVR 2006
- Fundamental
- Price
- PEN $256.69
- EVR $244.66
- Analyst Decision
- PEN Strong Buy
- EVR Buy
- Analyst Count
- PEN 16
- EVR 6
- Target Price
- PEN $299.73
- EVR $231.17
- AVG Volume (30 Days)
- PEN 433.2K
- EVR 424.4K
- Earning Date
- PEN 07-29-2025
- EVR 07-23-2025
- Dividend Yield
- PEN N/A
- EVR 1.36%
- EPS Growth
- PEN N/A
- EVR 63.41
- EPS
- PEN 1.08
- EVR 10.47
- Revenue
- PEN $1,240,100,000.00
- EVR $3,094,265,000.00
- Revenue This Year
- PEN $14.60
- EVR $7.34
- Revenue Next Year
- PEN $14.24
- EVR $20.26
- P/E Ratio
- PEN $239.29
- EVR $23.57
- Revenue Growth
- PEN 13.17
- EVR 27.09
- 52 Week Low
- PEN $148.00
- EVR $148.63
- 52 Week High
- PEN $310.00
- EVR $324.06
- Technical
- Relative Strength Index (RSI)
- PEN 40.56
- EVR 58.59
- Support Level
- PEN $249.09
- EVR $238.96
- Resistance Level
- PEN $265.48
- EVR $250.62
- Average True Range (ATR)
- PEN 6.58
- EVR 5.52
- MACD
- PEN 0.62
- EVR -0.69
- Stochastic Oscillator
- PEN 40.53
- EVR 73.44
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.
About EVR Evercore Inc.
Evercore is an independent investment bank that derives the majority of its revenue from financial advisory, including merger, acquisition, and restructuring advisory. It also has institutional equities trading, equity underwriting, and investment management businesses that account for around 20% of net revenue. The company was founded in 1996 and went public in 2006. Evercore had approximately 2,380 employees at the end of 2024, and about 75% of its revenue is derived from the United States.